FOR INFORMATION CONTACT:
Lori Gardner, Senior Director
Communications & Marketing
301.984.9496 ext. 226
For Immediate Release: February 2, 2012
Oncology Care Leaders Gather in Baltimore for Association of Community Cancer Centers 38th Annual National Meeting
Hospitals and Oncology Practices to Explore the New Realities Shaping Cancer Care
WHEN: Monday, March 12, 2012 – Wednesday, March 14, 2012
WHERE: Renaissance Baltimore Harborplace Hotel, Baltimore, Maryland
Leaders from the nation’s hospital-based cancer programs and oncology practices will gather in Baltimore, Maryland, for the Association of Community Cancer Centers’ (ACCC) 38th Annual National Meeting. Join us as the nation’s oncology experts explore the new realities facing cancer care today: oncology drug shortages, an increasing number of patients and a decreasing workforce, evolving coordinated care models, and new Commission on Cancer standards.
Gain fresh perspectives on the economic trends that will affect cancer programs nationwide and learn how hospitals can strengthen their cancer service line.
The full agenda is available at www.accc-cancer.org.
Here are meeting highlights that you won’t want to miss:
The Affordable Care Act Two Years Later
Tuesday, March 13, 11:00 am – 12:00 pm
Even with legal challenges and the November election on the horizon, The Affordable Care Act presses forward. Explore key aspects and requirements of the law that have already been implemented and the next steps, including state exchanges—standards for ongoing federal oversight, quality data reporting requirements, and the definition of essential health benefits for each state. Deborah E. Trautman, PhD, RN, from Johns Hopkins Medicine Center for Health Policy and Healthcare Transformation, presents.
Radiation Technology Cost-Benefit Analysis
Tuesday, March 13, 2:00 pm – 3:00 pm
Many radiation technologies, such as image-guided radiation therapy and proton therapy, come with a heavy price tag. A new proton therapy center, for example, can cost $100–140 million. At the same time, new Medicare rules in 2012 significantly affect radiation oncology reimbursement. Learn about the newest advances in radiation oncology technology and treatments and hear our panel weigh the benefits against the costs for providers and patients.
Drug Shortages: Ethics of Drug Distribution
Tuesday, March 13, 3:30 pm – 4:30 pm
Many facilities report they are temporarily modifying or suspending a chemotherapy regimen for their patients because they are unable to obtain a specific drug. At the same time, the oncology drug shortage has opened the door for so-called gray market companies that exploit the short supply, buying up drugs and then selling them to hospitals at massive markups. Find out how some cancer programs and practices ethically address the current crisis in drug distribution.
From AWP to ACOs: An Oncologist’s Journey
Tuesday, March 13, 4:30 pm – 5:30 pm
The business model of community oncology is evolving, and the choices an oncologist faces are expanding. Explore the pros and cons of going it alone in a small practice, joining a larger practice or a national network, becoming part of a local/regional network that integrates with the local/regional health system, or pursuing an employment model. Learn the key drivers of success, key relationships, and key challenges, and understand the range of choices an oncologist faces today.
Role and Importance of Patient Assistance Programs for Cancer Drug Access
Wednesday, March 14, 7:30 am – 8:30 am
Increasingly, payers are choosing not to cover certain cancer drugs or placing them on a specialty tier, leading to significant costs for patients. Community-based patient assistance programs can provide free drugs, co-pay assistance, and counseling to uninsured and underinsured patients with cancer. Learn how the design, operation, and management of these programs have significantly evolved during the past few years and understand trends in access to cancer drugs.
The Changing Landscape of Oncology
Explore the trends in cancer care and reimbursement, including consolidation, expansion, replacement of clinical technology, hiring, and financial health. Among the many findings from ACCC’s recent meeting “Navigating the Changing Landscape of Payment Models in Community Oncology” and from ACCC’s 2011 survey, “Cancer Care Trends in Community Cancer Centers,” are that 1) traditional reimbursement models are changing, 2) collaborative programs between payers and physicians are emerging, and 3) physician affiliations with cancer programs are increasing.
ACCC Legislative and Regulatory Update
Wednesday, March 14, 10:30 am – 11:15 am
Find out how cancer programs are navigating the cuts in drug reimbursements, removal of the prompt pay discount, and cuts in payments for bad debt.